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Introduction
Resilience and elastic recoil are properties conferred on
all vertebrate elastic tissues by elastic fibers (Cleary and
Gibson 1996; Debelle and Tamburro 1999). These com-
plex extracellular matrix biopolymers, assembled from
15 different proteins or glycoproteins, are composed
of two distinct morphological entities. The amorphous
component is made up of insoluble elastin, a highly
cross-linked and hydrophobic protein assembled from
soluble precursor proteins called “tropoelastins.” The
microfibrillar component of elastic fibers is composed of
several glycoproteins, of which the best known are the
fibrillins (fibrillin-1 and fibrillin-2). Elastic microfibrils
are thought to provide a three-dimensional scaffold for
the assembly of elastin during the formation of elastic
fibers. This elastogenesis occurs in most elastic tissues
during late prenatal and neonatal development. It is in-
soluble elastin that confers to elastic fibers the property
of elastic recoil.
In addition to the mechanical properties of resilience,
elastic fibers are unique in several other aspects as well.
Once synthesized in early development, elastic fibers
undergo very little turnover in normal adult tissues, with
the notable exception of the uterus. The elastic fibers
deposited in one’s aorta as a young child, for example,
are the same elastic fibers that one usually will die with.
In a variety of elastic-tissue diseases, however, new elas-
tic-fiber synthesis in adult tissue results in the aberrant
accumulation of dysfunctional elastic fibers. Examples
of such common disorders involving aberrant elastic-
fiber assembly include emphysema, hypertension, ac-
tinic elastosis, and aortic aneurysms.
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Primary Elastinopathies and Fibrillinopathies
To really understand the contribution of abnormal elas-
tic-fiber synthesis to the pathogenesis of such complex
elastic-tissue diseases, several investigators during the
last few years have turned to heritable, monogenic dis-
eases of elastic fibers. The first disease phenotype that
yielded significant insight into the pathogenesis of elastic
fibers was Marfan syndrome (MFS [MIM 154700]).
Mutations in FBN1, a gene that is on chromosome 15
and that encodes fibrillin-1, were shown to result in the
ocular, cardiovascular, and skeletal features so charac-
teristic of MFS (reviewed in Dietz and Pyeritz 1995;
Ramirez 1996). This work not only established a genet-
ic basis for understanding MFS but also contributed to
the realization that fibrillin-1 is a major component of
elastic microfibrils. A related disease, congenital con-
tractural arachnodactyly (MIM 121050), subsequently
was shown to be due to mutations in FBN2, a second
fibrillin gene on chromosome 5 (Putnam et al. 1995).
Mutations in the elastin gene also have been shown
to result in perturbations of elastic-fiber assembly. Pa-
tients with isolated supravalvular aortic stenosis (SVAS
[MIM 185500]) develop this stenotic arterial disorder
as a result of null mutations in the elastin gene (Urba´n
et al., in press). SVAS is also a feature in a complex
developmental disorder called “Williams-Beuren syn-
drome” (MIM 194050) in which patients are hemizy-
gous for the elastin gene (Ewart et al. 1993). In patients
with Williams syndrome, hemizygosity arises as a result
of a microdeletion of ∼1.5 Mb on chromosome 7, in-
volving 15 genes and including the elastin gene (for
review, see Francke 1999). Mutations in the elastin gene
have also very recently been shown to result in at least
some examples of an autosomal dominant form of a
heritable skin disorder called “cutis laxa” (adCL [MIM
123700]; Tassabehji et al. 1998; Zhang et al. 1999).
Patients with adCL are characterized by redundant and
inelastic skin, hernias, upper-airway obstruction, mild
dilatation of the aorta and great vessels, and, apart from
the presence of pulmonary-artery stenoses in both SVAS
and adCL, a phenotype strikingly dissimilar to SVAS.
Moreover, the elastin-gene mutations in adCL that have
been characterized to date are consistent with a domi-
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nant negative mechanism that, through the synthesis of
an aberrant tropoelastin, probably interferes with elas-
tin assembly. In patients with SVAS, the disruption of
elastic-fiber assembly results from reduced synthesis of
normal tropoelastin (Urba´n et al., in press). Two dif-
ferent classes of mutations in the tropoelastin gene, in
other words, seem to result in two, quite different
phenotypes.
The mutations in fibrillin genes result in disorders
affecting microfibril assembly and are referred to as
“fibrillinopathies.” Although no mutations have yet
been found in genes encoding other microfibrillar pro-
teins such as MFAPs (microfibril-associated proteins),
it’s entirely possible and indeed very likely that the fi-
brillinopathies will define a group of diseases due to
mutations in several of the genes encodingmicrofibrillar
proteins.
Elastinopathies are diseases due to mutations in just
the elastin gene. Together, both fibrillinopathies and
elastinopathies can be considered as primary disorders
of elastic fibers and as due to mutations in genes en-
coding proteins that are an integral part of elastic fibers.
Secondary Elastic-Fiber Pathologies
During the past few years, it has become apparent that
mutations in genes that encode proteins indirectly in-
volved in elastic-fiber assembly will also result in an
elastic-fiber pathology. Menkes syndrome, for example,
is an X-linked disorder of copper transport and is due
to a spectrum of mutations in a copper-transporting
ATPase gene, ATP7A (for review, see Kodama and Mur-
ata 1999). Altered copper transport leads to alterations
in the activity of a copper-dependent and elastic fi-
ber–associated lysyl oxidase that, through the formation
of desmosine cross-links using lysine residues in adjacent
tropoelastin molecules in a growing elastic fiber, is re-
sponsible for the formation of insoluble elastin. Con-
sequently, altered elastic-fiber morphology is a charac-
teristic feature of elastic tissues in patients with Menkes
syndrome (Pasquali-Ronchetti et al. 1994) and contrib-
utes to the complex phenotype in this disorder.
Very recently, Aleksander Hinek and his colleagues
have demonstrated impaired elastinogenesis in four dif-
ferent diseases that, like Menkes, arise through altered
transport mechanisms important to elastic-fiber assem-
bly. Unlike Menkes, however, these elastic-fiber pa-
thologies arise as a consequence of a transport defi-
ciency in the elastin-binding protein.
The 67-kD elastin-binding protein (EBP) chaperones
tropoelastin from intracellular sites of synthesis in the
RER, through the golgi and secretory vacuoles, to the
cell membrane (Hinek and Rabinovitch 1994). EBP is
the enzymatically inactive spliced variant of b-galac-
tosidase (called “S-Gal”) and a component of a non-
integrin cell-surface receptor that delivers tropoelastin
to the microfibrillar scaffold of developing elastic fibers
(Privitera et al. 1998). Binding of microfibrillar galac-
tosugars to EBP results in both the release of tropoe-
lastin and the recycling of the EBP back to the intra-
cellular endosomal compartment, for reassociationwith
newly synthesized tropoelastin (Hinek et al. 1995).
Hurler disease (mucopolysaccaridosis type I, or MPSI
[MIM 252800]) is an inherited metabolic storage dis-
order that is caused by a primary defect in lysosomal
a-L-iduronidase. MPSI is characterized by a complex
phenotype with skeletal, facial, and CNS abnormalities.
This deficiency causes an accumulation of both der-
matan sulfate and heparin sulfate, two galactosugar-
bearing glycosaminoglycans that could possibly disrupt
the chaperone function of the EBP and, in so doing,
disrupt elastin assembly. In a recent study of this dis-
order (Hinek and Wilson 2000), it is clear that the ac-
cumulation of dermatan sulfate by cultured skin fibro-
blasts from patients with Hurler disease does result in
both the functional inactivation of the EBP and an in-
ability of these fibroblasts to assemble elastic fibers. In-
terestingly, part of the MPSI phenotypic spectrum is an
obstructive coronary arteriopathy very similar to the
elastin arteriopathy that is observed in patients with
SVAS and that is characterized by reduced elastin
synthesis.
A similar functional deficiency in EBP has been
noted (Hinek et al. 2000a) in Costello syndrome (MIM
218040), which is characterized by redundant skin,
hyperkeratosis, facial dysmorphism, and short stature.
Although the primary genetic lesion in this complex
disorder is currently unknown, impaired deposition of
elastin previously had been observed in multiple tissues
from patients with Costello syndrome. In studying
elastogenesis in skin fibroblasts from patients with
Costello syndrome, therefore, Hinek and coworkers
observed a disruption of the normal association of EBP
and tropoelastin, as a consequence of the accumulation
of chondroitin sulfate–bearing proteoglycans, an ac-
cumulation that resulted in both the shedding of EBP
from the surface of Costello fibroblasts and impaired
elastogenesis.
Now, in an intriguing sequel to these earlier dem-
onstrations of impaired EBP function in diseases char-
acterized by increased galactosugar accumulation, Hi-
nek et al. (2000b [in this issue]) have demonstrated, in
an article in this issue of the Journal, that genetic defects
in the b-Gal gene that influence the expression of the
alternatively spliced isoform of b-Gal, S-Gal (EBP), will
result in defective assembly of elastic fibers (Hinek et
al. 2000b [in this issue]). Multiple mutations in the b-
Gal gene have previously been shown to be responsible
for two clinically distinct disorders, GM1-gangliosidosis
(MIM 230500, MIM 230600, and MIM 230650) and
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Morquio disease type B (mucopolysaccaridosis type
IVB, or MPS IVB [MIM 253010]). Using fibroblast cul-
tures from four patients with Morquio B disease with
b-Gal gene mutations encoding sequence variants in the
domain common to both b-Gal and EBP (or S-Gal), as
well as fibroblasts from two patients with GM1-gan-
gliosidosis with a missense mutation, in the b-Gal gene,
that does not affect the S-Gal splice variant, Hinek and
colleagues looked for deficiencies in EBP and for im-
pairment of elastic-fiber production. Very elegantly, this
study confirmed that b-Gal mutants that influenced S-
Gal synthesis resulted in both reduced EBP and deficient
elastin synthesis and accumulation. Conversely, b-Gal
mutants in skin fibroblasts from patients with GM1-
gangliosidosis that were deficient in only the lysosomal
variant of b-Gal and that synthesized normal levels of
S-Gal demonstrated normal accumulation of insoluble
elastin. Deficiencies in both S-Gal and elastin synthesis
provide, therefore, a possible mechanistic explanation
for the increased severity of connective-tissue disorders
in patients with Morquio B disease.
Conclusions
Taken together, these three recent studies by Hinek and
his colleagues emphasize that deficiencies in EBP-medi-
ated transport of tropoelastin will impair elastogenesis
and will contribute to an elastic-tissue phenotype.Hurler
disease, Costello syndrome, Morquio B disease, and
GM1-gangliosidosis therefore join a growing list of hu-
man elastic-fiber diseases in which the pathomechanism
that leads to aberrant elastic-fiber accumulation lies in
transport mechanisms secondary to fiber assembly.
There will certainly be other examples of such secondary
elastinopathies, and, in fact, one such emerging example
is an inherited disorder of elastic fibers that is called
“pseudoxanthoma elasticum,” or “PXE,”in which sev-
eral very recent reports have established that mutations
in a gene encoding an ABC transporter, ABCC6, are
responsible for defective elastogenesis (Bergen et al.
2000; Le Saux et al. 2000; Ringpfeil et al. 2000). How
aberrant transport by this ABC transporter results in
abnormal elastin or elastic-fiber accumulation is com-
pletely unknown at the moment, but it is to be hoped
that insight into this functional relationship will provide
a clearer understanding of elastic-fiber assembly, inmuch
the same manner as Hinek et al.’s work has done to
date.
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